CY-002

N/A

Report date: 2025/09/03 17:58:22
NME

Base Information

Drug NameCY-002
Drug Alias NameCY-002CY002CY002-243-1
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionSchlafen family member 12 bindersPDE3A-SLFN12 protein complex formation inducers
TargetsSchlafen family member 12
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Helioson Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Helioson Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A